KCNQ2 Channel as a Druggable Epilepsy Target: Advances in Pharmacological Modifiers

可药性 癫痫 医学 神经科学 加巴能 钠通道 临床试验 生物信息学 药物发现 丙戊酸 药理学 药物开发 脑病 神经发育障碍 钠通道阻滞剂
作者
Inn-Chi Lee,Shi-Bing Yang,Swee‐Hee Wong,Jiann‐Jou Yang,S Li
出处
期刊:Cns & Neurological Disorders-drug Targets [Bentham Science Publishers]
卷期号:25
标识
DOI:10.2174/0118715273455571260523060433
摘要

KCNQ2 encodes the Kv7.2 channel, which mediates the M-current and regulates neuronal excitability. Pathogenic variants of KCNQ2 are associated with a spectrum of neonatal epilepsies, ranging from self-limited familial neonatal epilepsy to severe Developmental and Epileptic Encephalopathy (DEE), characterized by early seizure onset within the first week after birth, seizure clustering, and poor long-term neurodevelopment. Despite advances in molecular diagnosis, current treatment options remain limited and are not specific to Kv7.2 modulation, underscoring the need for therapies that target the underlying KCNQ2 channel dysfunction. Pharmacological modifiers of Kv7- mediated currents, such as retigabine, have demonstrated the restoration of impaired M-currents, but safety concerns limit their clinical application. Recent progress has led to the development of nextgeneration Kv7 activators, such as XEN1101, as well as other investigational compounds with improved potency, selectivity, and tolerability. These agents have shown promise for the treatment of epilepsy in adults in both preclinical and clinical studies, but evidence in children remains limited. Indirect modulators acting through sodium channels, GABAergic pathways, or network-level mechanisms may provide seizure control but are less likely to address the underlying channel dysfunction or improve neurodevelopmental outcomes. Challenges persist in translating in vitro efficacy into treatable clinical outcomes, particularly in neonates with DEE. Safety considerations, biomarkers of treatment responsiveness, and neurodevelopmental effects require careful evaluation. Nonetheless, the evolving pharmacological landscape highlights KCNQ2 channels as attractive and druggable targets in epilepsy, offering opportunities for mechanism-based therapies that could transform the management of this rare but devastating DEE.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
222发布了新的文献求助10
刚刚
锦鲤君完成签到 ,获得积分10
刚刚
KyrieIrving发布了新的文献求助10
刚刚
刚刚
刚刚
刚刚
叮叮完成签到 ,获得积分10
1秒前
豆宇桫完成签到,获得积分20
1秒前
奋斗的猫咪完成签到,获得积分10
1秒前
科研通AI6.4的应助被淡然新竹采纳,获得10
1秒前
阿凡完成签到,获得积分10
1秒前
丘比特的应助被迷你的奎采纳,获得10
1秒前
重逢完成签到,获得积分10
2秒前
2秒前
杨一完成签到,获得积分20
2秒前
2秒前
3秒前
刻苦的语堂完成签到,获得积分10
3秒前
瑶瑶完成签到,获得积分10
3秒前
3秒前
3秒前
科目三的应助被蕾先生采纳,获得10
4秒前
4秒前
研友_ZAyqJZ发布了新的文献求助10
4秒前
山不见我完成签到,获得积分10
4秒前
5秒前
woo关闭了woo的文献求助
5秒前
5秒前
6秒前
6秒前
嘻嘻哈哈的应助被lxy采纳,获得10
6秒前
桐桐的应助被忐忑的滑板采纳,获得10
6秒前
故川完成签到,获得积分10
6秒前
失眠晓霜发布了新的文献求助10
7秒前
tcb发布了新的文献求助30
7秒前
8秒前
个性的紫安完成签到,获得积分10
8秒前
CodeCraft的应助被豆宇桫采纳,获得10
8秒前
8秒前
爱听歌的怀柔完成签到,获得积分20
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8169630
求助须知:如何正确求助?哪些是违规求助? 9562656
关于积分的说明 21766922
捐赠科研通 7761201
什么是DOI,文献DOI怎么找? 3430488
关于科研通互助平台的介绍 2554267
邀请新用户注册赠送积分活动 2475133